-

$undefined

N/A

(N/A)

Inhibikase Therapeutics :IKT

Location: | Industry: | Sector:

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

10.03M

Cash

7.94M

Avg Qtr Burn

-4.117M

Short % of Float

11.02%

Insider Ownership

10.46%

Institutional Own.

11.62%

Qtr Updated

06/30/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
IkT-001Pro Details Cancer, Hematologic malignancies, Gastric cancer	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Risvodetinib (IkT-148009) Details Neurodegenerative disease, Parkinson's disease Suspected Mover™ Susp. Mover™	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.